Skip to content
V$439.28+2.69(+0.62%)Visa Just Raised Its Dividend 16%. Is It a Better Buy Than Mastercard?8:17:32 AM ETCVS$80.90+0.91(+1.14%)RPT-BREAKINGVIEWS-CVS’s problem: investors trust the warning label8:16:38 AM ETCOP$139.45+2.51(+1.83%)STAK Energy Signs Long-Term Agreement to Bring North Slope Natural Gas to Market8:15:00 AM ETMU$759.18-36.28(-4.56%)Is Micron stock a Buy after crashing below $800?8:13:57 AM ETGOOG$289.99+2.69(+0.94%)Meta Paid 1.4 Times What Alphabet Did to Borrow in Euros8:08:00 AM ETCOP$139.45+2.51(+1.83%)ConocoPhillips Profit Rises as Oil Prices Climb8:06:00 AM ETTCPC$4.40+0.02(+0.46%)BlackRock TCP Capital Corp. Announces Third Quarter 2026 Financial Results Including Net Investment Income of $0.16 Per Share; Declares a Fourth Quarter Dividend of $0.17 Per Share8:05:07 AM ETINTC$56.82-1.46(-2.51%)Intel: I Warned Before The 40% Crash, Now I'm Bullish (Rating Upgrade)8:05:00 AM ETASML$1,458.78-37.36(-2.50%)Could $10,000 Invested in ASML Set You Up for Life?8:05:00 AM ETAVGO$317.35-8.35(-2.56%)Broadcom Stock Could Be Approaching a Major Turning Point. Here's the Price Target8:03:07 AM ETVZ$46.68+0.51(+1.10%)Verizon Makes the Holidays Simple with Our Best Deals and Rewards Just for Being a Customer8:01:25 AM ETSHEL$102.77+0.91(+0.89%)Transaction in Own Shares8:00:53 AM ETIBM$256.40+2.08(+0.82%)IBM, AMD, Oak Ridge National Laboratory launch quantum error correction platform8:00:48 AM ETMETA$634.53+4.53(+0.72%)Voters rejected AI data centers over resource concerns. Here's why measuring water usage is hard8:00:01 AM ETISRG$484.18+1.99(+0.41%)World’s First Fully Robotic Transoral Gastric Procedures Completed Using EndoQuest’s Endoluminal Surgical System8:00:00 AM ETGOOG$289.99+2.69(+0.94%)Alphabet: Search Disruption Vs. The Rise Of Carbon8:00:00 AM ETAAPL$355.21+5.70(+1.63%)The new moto buds ultra 27 take audio up a notch with Sound by Bose technology and bring AI live translation to consumers8:00:00 AM ETTM$216.81+17.35(+8.70%)2027 Toyota Tundra: A Bold New Chapter in Full-Size Pickup Excellence with Advanced Towing Tech and the New Trailhunter Package8:00:00 AM ETIBM$256.40+2.08(+0.82%)Oak Ridge National Laboratory, IBM, and AMD Launch New Co-Design Platform for Quantum Error Correction8:00:00 AM ETNVDA$196.70-3.59(-1.79%)Nvidia Stock Is Back at $200. What History Suggests Is the Floor.7:57:00 AM ETAAPL$355.21+5.70(+1.63%)Apple: Demand Is Not The Problem7:54:50 AM ETCOP$139.45+2.51(+1.83%)BRIEF-ConocoPhillips Says Qatar LNG Production Remained Constrained Through Q37:50:36 AM ETMCD$280.65+0.43(+0.15%)McDonald's Is Rallying, but Can You Sleep at Night Owning It?7:48:44 AM ETPLTR$166.92-4.78(-2.78%)Palantir's CEO Just Said What Wall Street Doesn't Want to Hear About AI7:47:36 AM ET

LQDA · NASDAQ

Liquidia Corporation

$47.85 +0.47 (+0.99%)

Company overview

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$4.3B
Employees
170
Headquarters
Morrisville, NC
CEO
Roger A. Jeffs
Listed
July 26, 2018
P/E
200.33
Dividend yield
0.00%

Company financials

Revenue
$288M
Gross profit
$264M
Operating income
$45.6M
EBITDA
$52M
Net income
$22.3M
EPS
$0.24
Total assets
$402M
Total debt
$185M
Gross margin
91.78%
Net margin
7.74%
Earnings yield
0.50%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

19.4638.7157.9677.2196.46
LQDA 1D NASDAQ O43.32H51.11L43.24C47.38+5.18 (+12.27%)Vol4.51M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
LQDALiquidia Corporation Press release Liquidia Corporation to Report Third Quarter 2026 Financial Results on November 10, 2026 GlobeNewswire
LQDALiquidia Corporation Stock news Liquidia Gears Up to Report Q3 Earnings: What Can Investors Expect? Zacks Investment Research
LQDALiquidia Corporation Stock news Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy? Zacks Investment Research
LQDALiquidia Corporation Legal Bronstein, Gewirtz & Grossman, LLC Is Investigating Liquidia Corporation (LQDA) And Encourages Shareholders to Connect ACCESS Newswire
LQDALiquidia Corporation Legal Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Liquidia Corporation (LQDA) And Encourages Shareholders to Reach Out ACCESS Newswire
LQDALiquidia Corporation Legal Bronstein, Gewirtz & Grossman, LLC Encourages Liquidia Corporation (LQDA) Stockholders to Inquire about Securities Investigation ACCESS Newswire
LQDALiquidia Corporation Stock news LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label Zacks Investment Research
LQDALiquidia Corporation Stock news Liquidia shares surge 25% as settlement ends United Therapeutics litigation Proactive Investors
LQDALiquidia Corporation Legal Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Liquidia Corporation (LQDA) and Encourages Investors to Learn More About the Investigation ACCESS Newswire
LQDALiquidia Corporation Stock news United Therapeutics and Liquidia Just Ended Their Patent War. Liquidia Stock Popped 42% 24/7 Wall Street
LQDALiquidia Corporation Stock news Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday Benzinga
LQDALiquidia Corporation Stock news This Biotech Stock Surges 37% on Patent Settlement. ‘Better Than the Best-Case Scenario. Barrons
LQDALiquidia Corporation Stock news This Albemarle Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday Benzinga
LQDALiquidia Corporation Legal LIQUIDIA CORPORATION LQDA INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 57.2% Share Drop Business Wire
LQDALiquidia Corporation Press release Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH GlobeNewswire
LQDALiquidia Corporation Legal Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky GuruFocus
LQDALiquidia Corporation Legal Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky For Liquidia Corporation (NASDAQ: LQDA) shareholders, a court finding that Yutrepia infringed two valid claims of United Therapeutics' '327 patent... PR Newswire
LQDALiquidia Corporation Stock news First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday Benzinga
LQDALiquidia Corporation Legal Liquidia Corporation Investigation Initiated: Levi & Korsinsky Investigates The Officers and Directors of Liquidia Corporation (LQDA) ACCESS Newswire
LQDALiquidia Corporation Legal Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Liquidia Corporation (LQDA) And Encourages Stockholders to Reach Out ACCESS Newswire
FAQ

Questions about Liquidia Corporation

What does Liquidia Corporation do?
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
What is LQDA's market cap?
Liquidia Corporation (LQDA) is a listed stock with a live quote. The latest market cap on this page is $4.3B.
Where is Liquidia Corporation headquartered?
Liquidia Corporation is headquartered in Morrisville, NC.
How do I get LQDA news from the API?
Call GET /v1/news?tickers=LQDA. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does LQDA news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for LQDA, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the LQDA price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.